Literatur
-
1
Beguin Y, Lampertz S, Bron D, Fillet G.
Serum erythropoietin in chronic lymphocytic leukaemia.
Br J Haematol.
1996;
93
154-156
-
2
Davis H P, Brown H.
Epoetin alfa for anaemia of chronic leukaemia.
Lancet.
1991;
337
47
-
3
Galeza-Obrepalska B, Dwilewicz-Trojaczek J, Paszkowska M, Kuratowska Z.
Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia (Article in Polish).
Pol Tyg Lek.
1996;
51
285-288
-
4
Hallek M, Schmitt B, Emmerich B, Stein H.
Chronisch lympyhatische Leukämie - Teil 1: Diagnostik.
Dtsch Med Wochenschr.
2001;
126
687-689
-
5
Hallek M, Schmitt B, Emmerich B, Stein H.
Chronisch lympyhatische Leukämie - Teil 2: Therapie.
Dtsch Med Wochenschr.
2001;
126
690-694
-
6
Haber J, Spicka I, Petruzelka L, Koleskova E, Straub J, Jonasova A, Pospisilova B.
Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases - chronic lymphadenosis and multiple myeloma (Article in Czech).
Vnitr Lek.
1996;
42
262-267
-
7
Longo G, Fiorani C, Bonacorsi G, Vanzanelli P, Sani F, Bevini M, Curci G, Torelli U.
Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease (Article in Italian).
Recenti Prog Med.
1992;
83
449-454
-
8
Molica S.
Erythropoietin treatment of anaemia associated with lymphoproliferative disorders.
Eur J Cancer.
1993;
29A
1499-1500
-
9
Pangalis G A, Poziopoulos C, Angelopoulou M K, Siakantaris M P, Panayiotidis P.
Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.
Br J Haematol.
1995;
89
627-629
-
10
Siakantaris M P, Angelopoulou M K, Vassilakopoulos T P, Dimopoulou M N, Kontopidou F N, Pangalis G A.
Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Leuk Lymphoma.
2000;
40
141-147
-
11
Cheung W, Minton N, Gunawardena K K.
Pharmacokinetics and pharmacodynamics of epoetin alfa once and three times weekly.
Eur J Clin Pharmacol.
2001;
57
411-418
Autor
Dr. H. Richard Barthel
Praxis für Innere Medizin und Rheumatologie
Herzog-Adolph-Straße 4
61462 Königstein
Email: hrbarthel@hotmail.com
